Brain Vascular and Neurocognitive Health

Description

The overall research objective of this proposal is to determine the acute and chronic impact of transcranial photobiomodulation on indices of cerebral vascular health and neurocognitive function.

Conditions

Cognitive Decline, Cognitive Dysfunction, Alzheimer Disease, Vascular Disease, Peripheral

Talk to us

Study Overview

On this page

Study Details

Study overview

The overall research objective of this proposal is to determine the acute and chronic impact of transcranial photobiomodulation on indices of cerebral vascular health and neurocognitive function.

Brain Vascular and Neurocognitive Health

Brain Vascular and Neurocognitive Health

Condition
Cognitive Decline
Intervention / Treatment

-

Contacts and Locations

Arlington

UT Arlington - Science and Engineering Innovation and Research Building, Arlington, Texas, United States, 76010

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Both men and women between the ages of 18-80 and of any race/ethnicity will be included in this study.
  • * Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then the investigators may still opt to proceed with data collection.
  • * Abnormal results from the blood screening will not impact eligibility for the study.
  • * Individuals with brain injuries/surgeries in a year before the study and individuals who can not provide consent on their own will be excluded from participation.
  • * Pregnant subjects, women who are breast feeding, and children (i.e. younger than 18) will not be recruited for the study. This will be assessed via self-report.
  • * If a subject has any allergies to spandex/lycra, the subject will be excluded. However, latex allergies are not contraindicated.
  • * Individuals with cardiac pacemakers and/or implantable cardioverter defibrillators and individuals with epilepsy will be excluded.

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

The University of Texas at Arlington,

Robert M Brothers, PhD, PRINCIPAL_INVESTIGATOR, University of Texas at Arlington

Study Record Dates

2025-12-31